[Immunogenicity of recombinant influenza virus vaccines (author's transl)]. 1979

M Higashihara, and Y Suzuki, and Y Saito, and Y Igarashi, and I Yoshioka, and M Takahashi, and Y Miki

UI MeSH Term Description Entries
D007252 Influenza Vaccines Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The flu vaccines may be mono- or multi-valent, which contains one or more ALPHAINFLUENZAVIRUS and BETAINFLUENZAVIRUS strains. Flu Vaccine,Influenzavirus Vaccine,Monovalent Influenza Vaccine,Universal Flu Vaccine,Universal Influenza Vaccine,Flu Vaccines,High-Dose Trivalent Influenza Vaccine,Influenza Vaccine,Influenza Virus Vaccine,Influenza Virus Vaccines,Influenzavirus Vaccines,Intranasal Live-Attenuated Influenza Vaccine,LAIV Vaccine,Monovalent Influenza Vaccines,Quadrivalent Influenza Vaccine,Trivalent Influenza Vaccine,Trivalent Live Attenuated Influenza Vaccine,Universal Flu Vaccines,Universal Influenza Vaccines,Flu Vaccine, Universal,High Dose Trivalent Influenza Vaccine,Influenza Vaccine, Monovalent,Influenza Vaccine, Quadrivalent,Influenza Vaccine, Trivalent,Influenza Vaccine, Universal,Intranasal Live Attenuated Influenza Vaccine,Vaccine, Flu,Vaccine, Influenza,Vaccine, Influenza Virus,Vaccine, Influenzavirus,Vaccine, LAIV,Vaccine, Monovalent Influenza,Vaccine, Quadrivalent Influenza,Vaccine, Trivalent Influenza,Virus Vaccine, Influenza
D008297 Male Males
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D011995 Recombination, Genetic Production of new arrangements of DNA by various mechanisms such as assortment and segregation, CROSSING OVER; GENE CONVERSION; GENETIC TRANSFORMATION; GENETIC CONJUGATION; GENETIC TRANSDUCTION; or mixed infection of viruses. Genetic Recombination,Recombination,Genetic Recombinations,Recombinations,Recombinations, Genetic
D005260 Female Females
D006389 Hemagglutinins, Viral Specific hemagglutinin subtypes encoded by VIRUSES. Viral Hemagglutinin,Viral Hemagglutinins,Hemagglutinin, Viral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

M Higashihara, and Y Suzuki, and Y Saito, and Y Igarashi, and I Yoshioka, and M Takahashi, and Y Miki
April 2010, Viral immunology,
M Higashihara, and Y Suzuki, and Y Saito, and Y Igarashi, and I Yoshioka, and M Takahashi, and Y Miki
June 1977, MMW, Munchener medizinische Wochenschrift,
M Higashihara, and Y Suzuki, and Y Saito, and Y Igarashi, and I Yoshioka, and M Takahashi, and Y Miki
June 1974, Therapeutische Umschau. Revue therapeutique,
M Higashihara, and Y Suzuki, and Y Saito, and Y Igarashi, and I Yoshioka, and M Takahashi, and Y Miki
August 2008, Current opinion in investigational drugs (London, England : 2000),
M Higashihara, and Y Suzuki, and Y Saito, and Y Igarashi, and I Yoshioka, and M Takahashi, and Y Miki
January 1980, Comparative immunology, microbiology and infectious diseases,
M Higashihara, and Y Suzuki, and Y Saito, and Y Igarashi, and I Yoshioka, and M Takahashi, and Y Miki
January 1969, Bulletin of the World Health Organization,
M Higashihara, and Y Suzuki, and Y Saito, and Y Igarashi, and I Yoshioka, and M Takahashi, and Y Miki
June 1976, The Kitasato archives of experimental medicine,
M Higashihara, and Y Suzuki, and Y Saito, and Y Igarashi, and I Yoshioka, and M Takahashi, and Y Miki
December 1975, Deutsche medizinische Wochenschrift (1946),
M Higashihara, and Y Suzuki, and Y Saito, and Y Igarashi, and I Yoshioka, and M Takahashi, and Y Miki
September 2013, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
M Higashihara, and Y Suzuki, and Y Saito, and Y Igarashi, and I Yoshioka, and M Takahashi, and Y Miki
October 2012, Acta naturae,
Copied contents to your clipboard!